May 13, 2026 04:16AM
May 12, 2026 07:26AM
Apr 21, 2026 04:35PM
Apr 20, 2026 06:39AM
Apr 15, 2026 11:16AM
Apr 9, 2026 06:40AM
Mar 20, 2026 04:50AM B.Riley Reiterates Buy Rating on Ovid Therapeutics Inc (OVID)
Mar 19, 2026 03:07PM
Mar 19, 2026 10:28AM
Dec 11, 2025 02:23AM
Nov 17, 2025 06:07AM
Nov 12, 2025 08:05AM
Nov 12, 2025 07:01AM
Oct 9, 2025 12:38AM Oppenheimer Upgrades Ovid Therapeutics Inc (OVID) to Outperform
Oct 6, 2025 04:37AM
Oct 3, 2025 01:58PM
Oct 3, 2025 07:00AM
Aug 25, 2025 06:43AM
Aug 13, 2025 07:01PM
Aug 13, 2025 06:06AM
Aug 8, 2025 07:51AM B.Riley Assumes Ovid Therapeutics Inc (OVID) at Buy
Jun 25, 2025 08:02AM
May 27, 2025 06:38AM
May 13, 2025 05:28PM
Mar 24, 2025 06:42AM
Mar 24, 2025 04:55AM
Mar 11, 2025 04:29PM
Mar 3, 2025 08:03AM Ovid Therapeutics (OVID) Appoints Stelios Papadopoulos to its Board
Feb 13, 2025 05:51PM
Jan 29, 2025 09:54AM
Nov 12, 2024 04:45PM
Sep 30, 2024 07:27AM
Sep 27, 2024 06:28AM
Sep 26, 2024 08:01AM
Sep 11, 2024 08:01AM Ovid Therapeutics (OVID): Meg Alexander Takes on Expanded Role as President and COO
Aug 14, 2024 06:13AM
Aug 13, 2024 08:13AM
Aug 8, 2024 08:01AM
Jul 10, 2024 08:08AM
Jul 2, 2024 10:20AM
Jul 2, 2024 06:42AM
Jul 1, 2024 08:02AM Ovid Therapeutics (OVID) and Graviton Bioscience Announce Topline Data from a Phase 1 Clinical Trial Studying OV888/GV101 Capsule, a Potential First-In-Class Therapy for Cerebral Cavernous Malformatio
Jun 18, 2024 09:55AM
Jun 18, 2024 06:44AM
Jun 18, 2024 06:32AM
Jun 18, 2024 04:51AM
Jun 17, 2024 12:16PM
Jun 17, 2024 10:15AM
Jun 17, 2024 06:56AM Ovid Therapeutics (OVID) Reports on Takeda’s Announcement of Phase 3 Data for Soticlestat
Apr 20, 2021 09:25AM

416,803 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All